Innospec Inc. (IOSP) stock
IOSPNasdaqChemicals & Allied ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 13/3015% below fair value
$78.01−1.16 (-1.47%)
Close on Nov 17, 2026Market cap $1.92BP/E –Yield 2.19%
Innospec total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Innospec's total debt was $0 at Mar 31, 2021. For fiscal 2020 it was $0, down 100.0% from the year before. The highest annual figure on record is $268.80M in fiscal 2016.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2020 | Dec 31, 2020 | $0 | -100.0% |
| FY2019 | Dec 31, 2019 | $58.60M | -71.8% |
| FY2018 | Dec 31, 2018 | $207.60M | -4.9% |
| FY2017 | Dec 31, 2017 | $218.40M | -18.8% |
| FY2016 | Dec 31, 2016 | $268.80M | +104.3% |
| FY2015 | Dec 31, 2015 | $131.60M | -5.6% |
| FY2014 | Dec 31, 2014 | $139.40M | -5.8% |
| FY2013 | Dec 31, 2013 | $148.00M | +393.3% |
| FY2012 | Dec 31, 2012 | $30.00M | -14.3% |
| FY2011 | Dec 31, 2011 | $35.00M | -25.5% |
| FY2010 | Dec 31, 2010 | $47.00M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2021 | Mar 31, 2021 | $0 | -100.0% |
| Q4 FY2020 | Dec 31, 2020 | $0 | -100.0% |
| Q3 FY2020 | Sep 30, 2020 | $0 | -100.0% |
| Q2 FY2020 | Jun 30, 2020 | $38.80M | -75.4% |
| Q1 FY2020 | Mar 31, 2020 | $58.70M | -71.8% |
| Q4 FY2019 | Dec 31, 2019 | $58.60M | -71.8% |
| Q3 FY2019 | Sep 30, 2019 | $131.20M | -41.4% |
| Q2 FY2019 | Jun 30, 2019 | $158.00M | -29.4% |
| Q1 FY2019 | Mar 31, 2019 | $207.80M | -2.7% |
| Q4 FY2018 | Dec 31, 2018 | $207.60M | -4.9% |
| Q3 FY2018 | Sep 30, 2018 | $223.90M | -2.4% |
| Q2 FY2018 | Jun 30, 2018 | $223.80M | -10.2% |
| Q1 FY2018 | Mar 31, 2018 | $213.60M | -10.6% |
| Q4 FY2017 | Dec 31, 2017 | $218.40M | -18.8% |
| Q3 FY2017 | Sep 30, 2017 | $229.30M | +60.3% |
| Q2 FY2017 | Jun 30, 2017 | $249.10M | – |
| Q1 FY2017 | Mar 31, 2017 | $239.00M | – |
| Q4 FY2016 | Dec 31, 2016 | $268.80M | – |
| Q3 FY2016 | Sep 30, 2016 | $143.00M | – |
See a number that looks wrong?